Health crisis in a bottle: Rajasthan govt bans cough syrup batch after patients fall ill in Bharatpur, Sikar

Written By :  MD Bureau
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2025-10-01 13:30 GMT   |   Update On 2025-10-01 13:24 GMT
Advertisement

Jaipur: The Rajasthan Medical Services Corporation Limited (RMSCL) has imposed a ban on the distribution and use of a batch of cough syrup following reports of adverse reactions in Bharatpur and Sikar districts.

Patients reported alarming symptoms, including vomiting, drowsiness, anxiety, dizziness, restlessness, and even unconsciousness, after taking the medication.

Medical and Health Minister Gajendra Singh Khinvsar directed RMSCL to conduct an urgent probe and take immediate action upon receiving the complaints. Acting swiftly, RMSCL suspended the use of the Dextromethorphan HBr Syrup IP 13.5mg/5ml (Batch No. 440) pending test results.

Advertisement

Principal Secretary of the Medical and Health Department, Gayatri Rathore, confirmed that statutory samples were collected by Drug Control Officers and forwarded to the State Drug Testing Laboratory for quality analysis. She said further steps will be taken once the test results are available.

As per IANS, RMSCL has also ordered a ban on 19 other batches of the same drug supplied by the concerned manufacturer. RMSCL Managing Director Pukhraj Sain emphasised that strict quality control procedures are in place under the Chief Minister’s Free Medicine Scheme.

Every drug batch supplied is first tested in approved laboratories, and only medicines meeting prescribed standards are released for hospital use. If any batch fails, it is barred from distribution. In cases where complaints are received, drugs are retested at the State Drug Testing Laboratory to ensure public safety. Officials stressed that public health remains the government’s top priority and assured that necessary regulatory action will follow based on laboratory findings.

Patients have been advised to immediately discontinue use of the affected batches until further notice. The incident has raised concerns over drug safety standards, but authorities have reiterated their commitment to strict monitoring and swift corrective measures to protect patients.

A 5-year-old child died after reportedly consuming cough syrup supplied under the government’s free medicine scheme in Sikar district. The family alleged that the child, identified as Nityansh, stopped breathing immediately after taking the dose.

Similar incidents have surfaced in Srimadhopur and Bharatpur. In Sikar, three children reportedly fell ill after consuming the same cough syrup. In Bharatpur, even a doctor who examined the children later experienced health complications after consuming the medicine.

The most recent case occurred in Khori Brahmanan village of Sikar, where Nityansh’s family claims that the cough syrup provided at a government hospital was directly responsible for his sudden death.

Tags:    
Article Source : with inputs

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News